The intestinal microbiota and immune system have evolved a reciprocal relationship that maintains homeostasis and mutualism. The adaptive immune system, which emerged in vertebrates, enables efficient immune responses to diverse microbes, but also contributes to immune-mediated diseases linked to the microbiota. The microbiota, which contains over 100 times more genes than the human genome, plays a crucial role in nutrient metabolism and immune regulation. The microbiota benefits from the warm, nutrient-rich environment of the gut, while the host benefits from the microbiota's metabolic functions. However, dysbiosis—alterations in microbiota composition—can lead to immune-mediated diseases such as inflammatory bowel disease, rheumatoid arthritis, and multiple sclerosis. The coevolution of the microbiota and adaptive immunity has allowed vertebrates to harness a complex intestinal microbiota. The adaptive immune system recognizes and remembers both beneficial and harmful microbes, helping to maintain a balance between mutualism and host defense. The development of the immune system is influenced by the microbiota, with maternal transmission playing a key role in shaping the neonatal microbiome. The microbiota also influences the development of gut-associated lymphoid tissues (GALT), which are essential for immune surveillance. Innate immune pathways, including pattern recognition receptors (PRRs), help the host sense and restrain the microbiota. The intestinal epithelium, which is a key barrier, interacts with the microbiota through specialized cells and signaling pathways. The microbiota also influences the development of regulatory T cells, which help maintain immune tolerance. Effector T cells, such as Th17 cells, play a role in mucosal defense but can also contribute to inflammation when dysregulated. The balance between regulatory and effector immune responses is critical for maintaining homeostasis and preventing disease. Understanding the interactions between the microbiota and the immune system has important implications for the treatment and prevention of immune-mediated diseases.The intestinal microbiota and immune system have evolved a reciprocal relationship that maintains homeostasis and mutualism. The adaptive immune system, which emerged in vertebrates, enables efficient immune responses to diverse microbes, but also contributes to immune-mediated diseases linked to the microbiota. The microbiota, which contains over 100 times more genes than the human genome, plays a crucial role in nutrient metabolism and immune regulation. The microbiota benefits from the warm, nutrient-rich environment of the gut, while the host benefits from the microbiota's metabolic functions. However, dysbiosis—alterations in microbiota composition—can lead to immune-mediated diseases such as inflammatory bowel disease, rheumatoid arthritis, and multiple sclerosis. The coevolution of the microbiota and adaptive immunity has allowed vertebrates to harness a complex intestinal microbiota. The adaptive immune system recognizes and remembers both beneficial and harmful microbes, helping to maintain a balance between mutualism and host defense. The development of the immune system is influenced by the microbiota, with maternal transmission playing a key role in shaping the neonatal microbiome. The microbiota also influences the development of gut-associated lymphoid tissues (GALT), which are essential for immune surveillance. Innate immune pathways, including pattern recognition receptors (PRRs), help the host sense and restrain the microbiota. The intestinal epithelium, which is a key barrier, interacts with the microbiota through specialized cells and signaling pathways. The microbiota also influences the development of regulatory T cells, which help maintain immune tolerance. Effector T cells, such as Th17 cells, play a role in mucosal defense but can also contribute to inflammation when dysregulated. The balance between regulatory and effector immune responses is critical for maintaining homeostasis and preventing disease. Understanding the interactions between the microbiota and the immune system has important implications for the treatment and prevention of immune-mediated diseases.